Decline in Newborn Vitamin K Shots Drives 47 Percent Rise in Infant Bleeding Risk

For more than six decades, the intramuscular Vitamin K injection has been a quiet, routine fixture of the American delivery room. Administered within hours of birth, the single shot effectively eliminated a devastating newborn bleeding disorder. Now, a growing wave of parental refusal is rolling back that public health victory, driving a sharp increase in preventable infant hemorrhages.[1][3]

A comprehensive analysis of 5.2 million United States births, published Thursday in the Journal of the American Medical Association, quantifies the fallout of this shifting behavior. Researchers at the Children's Hospital of Philadelphia (CHOP) found that the proportion of newborns missing the prophylactic shot more than doubled over an eight-year period. The refusal rate climbed from 3.1 percent in 2017 to 6.8 percent in 2025.[2][3]

That decline in uptake translates directly to clinical harm. Infants who did not receive the Vitamin K injection faced a 47 percent higher risk of experiencing a bleeding event during their first six months of life. The data showed 288 bleeding incidents per 10,000 births among non-recipients, compared to 186 per 10,000 among those who received the standard prophylaxis.[2][3]

The CHOP investigators drew their conclusions by analyzing de-identified electronic health records through the Epic Cosmos research platform. The massive dataset encompassed hospitals and clinics across all 50 states and Washington, D.C., tracking infants born between 35 and 43 weeks of gestation. The researchers meticulously adjusted their models for variables including maternal age, insurance status, race, and neighborhood-level social vulnerability.[2][3]

"While bleeding risk increased for all babies over the course of the study period, the excess risk among infants without vitamin K was striking and present in every year of the study," said Dr. Kristan Scott, the study's lead author and an assistant professor at Emory University School of Medicine. Scott conducted the research while serving as a postdoctoral fellow at CHOP.[3]

The Threat Of Brain Hemorrhage

The most severe consequence of skipping the injection is a dramatic rise in bleeding within or around the brain. The CHOP analysis revealed that babies without documented Vitamin K administration had more than twice the risk of intracranial hemorrhage. The incidence reached 33 cases per 10,000 births for non-recipients, starkly higher than the 13 cases per 10,000 observed in the protected group.[3]

"The difference was particularly concerning for bleeding in or around the brain, a potentially life-threatening complication," said Dr. Kevin Dysart, a senior study co-author and attending neonatologist at CHOP. Dysart noted that infant death during the initial birth hospitalization, when accompanied by a bleeding diagnosis, was also significantly more common among those who missed the shot.[3]

A parallel study by Virginia Commonwealth University (VCU) researchers, published simultaneously in JAMA Pediatrics, tracked the broader national surge. Between 2017 and 2025, the rate of diagnosed Vitamin K deficiency in infants aged zero to six months climbed from 11.8 to 37.3 per 100,000. Actual cases of Vitamin K deficiency bleeding (VKDB) more than quadrupled, rising from 24.0 to 107.4 per 100,000.[1][4]

The clinical outcomes for infants who suffer these severe bleeds are often catastrophic. "Vitamin K-deficient bleeding can be very serious in babies," said Dr. Elizabeth Wolf, an associate professor of pediatrics at VCU and lead author of the JAMA Pediatrics study. "When the bleeding occurs in the brain, it can result in permanent neurologic damage or even death."[1][4]

Why Newborns Lack Vitamin K

The biological vulnerability of a newborn makes the prophylactic injection necessary. Vitamin K is a fat-soluble nutrient essential for the liver to activate four specific blood-clotting proteins: factors II, VII, IX, and X. Without adequate levels of this vitamin, the human body simply cannot form the clots required to stop routine or spontaneous bleeding.[1][4]

Infants are born inherently deficient in Vitamin K. Only minuscule amounts of the nutrient successfully cross the placenta during pregnancy. Furthermore, human breast milk contains very low concentrations of Vitamin K, leaving exclusively breastfed infants at a distinct disadvantage compared to those receiving fortified commercial formulas.[4]

In older children and adults, the bacteria living in the gastrointestinal tract synthesize a significant portion of the body's Vitamin K requirement. However, a newborn's gut microbiome is essentially sterile at birth. It takes roughly six months for the infant's digestive system to mature and for solid foods to be introduced, bridging the dangerous nutritional gap.[4]

This biological timeline creates a window of extreme vulnerability known as late-onset Vitamin K deficiency bleeding. Occurring anywhere from one week to six months of age, late VKDB is the most feared form of the disorder. Because the bleeding often happens spontaneously inside the brain without any preceding head trauma, parents may not realize their child is hemorrhaging until severe neurological symptoms appear.[1][4]

When late VKDB does manifest externally, the warning signs can be subtle before escalating rapidly. Infants may develop unexplained bruising, persistent bleeding from the umbilical cord stump, or prolonged bleeding following a routine heel prick. In severe cases, the 30 to 60 percent risk of intracranial hemorrhage can result in seizures, permanent brain damage, or death.[1][4]

The Roots Of Parental Refusal

The American Academy of Pediatrics has universally recommended the intramuscular injection since 1961, achieving a massive reduction in late VKDB globally. Yet, the recent surge in parental refusal stems from a complex mix of modern anxieties. Many parents declining the shot express a desire for a "natural" birth experience, seeking to minimize medical interventions and painful needle pokes for their newborn.[1][4]

More recently, the injection has become entangled in the broader erosion of trust in public health institutions. Although Vitamin K is a nutrient and not a vaccine, its delivery via a needle has caused it to be swept up in rising anti-vaccine sentiment. Researchers note that the steepest increases in refusal coincide with the heightened medical skepticism that accelerated during the COVID-19 pandemic.[4]

"Similar to the recent measles outbreaks, we are seeing the real-world implications of growing mistrust of doctors and public health professionals," Wolf said. "We need clear messaging from all levels of public health about the benefits of vitamin K administration for newborns."[4]

AI

Exploring Harm Reduction Alternatives

As refusal rates for the intramuscular injection climb, some pediatricians are debating whether the United States should adopt a harm-reduction strategy. In several European nations, including France, Germany, Switzerland, and the Netherlands, oral Vitamin K drops are routinely offered either as the primary standard of care or as a secondary alternative for parents who refuse the needle.[1]

However, the oral formulation is demonstrably less effective at preventing the dangerous late-onset form of VKDB. Because the nutrient is absorbed inconsistently through the infant's immature digestive tract, the oral method requires a strict regimen of multiple doses administered over several months. Missing a single follow-up dose leaves the infant vulnerable to sudden hemorrhaging.[1]

Despite its lower efficacy, offering the oral drops might save lives if the alternative is no protection at all. "Although the oral form can be less effective in preventing late vitamin K deficiency, a harm-reduction approach that offers oral vitamin K as a second-line alternative may be warranted in the U.S. if rejection of injectable vitamin K continues," Wolf and her colleagues wrote.[1]

For now, the medical consensus remains firmly behind the single, immediate injection. CHOP researchers estimate that for every 114 newborns who miss the shot, one additional infant will suffer a bleeding event in their first six months. As the refusal rate approaches seven percent nationally, pediatricians face an urgent mandate to rebuild trust before a highly preventable disorder claims more lives.[3]